Merck Applauds Colombia for First PAHO/WHO Verification of Elimination of River Blindness

Dateline City:  WHITEHOUSE STATION, N.J. Historic Milestone Reflects Successful Collaboration Among MECTIZAN® Donation Program and Partners WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, applauds the government of Colombia whose work with the MECTIZAN® Donation Program and The Carter Center-sponsored Onchocerciasis Elimination Program for the Americas led to today’s Pan American Health Organization, the World Health Organization’s Regional Office for the Americas (PAHO/WHO), verification of Colombia as the first country in the world to eliminate the transmission of river blindness (onchocerciasis), using MECTIZAN (iv Language:  English Contact:  MerckLainie Keller, 908-423-4187 Ticker Slug:  Ticker: MRK Exchange: NYSE read more
Source: Merck.com - Corporate News - Category: Pharmaceuticals Authors: Tags: Corporate News Corporate Responsibility News Latest News Source Type: news